Comprehensive Testing Capabilities Primera Analytical Solutions offers a wide range of bioanalytical and release testing services, including advanced methods like cell-based assays, impurity analysis, and bioequivalence studies, making them a one-stop partner for pharmaceutical companies seeking end-to-end analytical support.

Specialization in Cell & Gene Therapy With expertise in cell potency assays, FACS, and qPCR, Primera is well-positioned to support growing cell and gene therapy markets, presenting opportunities to collaborate with biotech firms expanding their manufacturing capacities.

Strong Regulatory Standing Being in good standing with the FDA and adhering to GLP and GMP standards enhances Primera’s credibility, making them a highly attractive partner for companies needing validated testing and compliance for new drug submissions or manufacturing scale-up.

Potential for Service Expansion Primera’s advanced analytical techniques, such as HRMS and extractable leachable studies, open doors for upselling additional specialized services to current clients and attracting new clients requiring high-complexity testing.

Growth within Pharmaceutical Sector With a revenue range of $50M to $100M, Primera's positioning amidst industry leaders indicates significant growth potential, especially by targeting emerging biotech firms and international partners looking for reliable CRO services in the pharmaceutical and biotech sectors.